Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

NCT02195089 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia

Interventions

DRUG: BLS_ILS_E710c 500mg
DRUG: BLS_ILB_710c 1000mg
DRUG: BLS_ILS_E710c 1500mg

Sponsor

BioLeaders Corporation